SCHEMBL5358648

SCHEMBL5358648

O=C1Nc2ccc(I)cc2C1=Cc1ccc(F)cc1F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 3/20 0.60
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
RPS6KA3 P51812 1/20 0.54
MAPT P10636 3/20 0.52
RAF1 P04049 3/20 0.52
APP P05067 2/20 0.52
MAP1LC3B Q9GZQ8 2/20 0.52
NTRK1 P04629 2/20 0.52
EGFR P00533 1/20 0.52
ARAF P10398 1/20 0.52
PIM1 P11309 1/20 0.52
BRAF P15056 1/20 0.52
CSNK2A1 P68400 1/20 0.52
PIM3 Q86V86 1/20 0.52
SIRT2 Q8IXJ6 1/20 0.52
SIRT1 Q96EB6 1/20 0.52
MYOC Q99972 1/20 0.52
DYRK4 Q9NR20 1/20 0.52
SIRT3 Q9NTG7 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638267 0.90 FLT3 (0.71) FLT3MEN1KMT2ARPS6KA3NTRK1
SCHEMBL7136535 0.90 FLT3 (0.60) FLT3MEN1KMT2ARPS6KA3MAPT
SCHEMBL7138293 0.85 NPC1 (0.70) FLT3MEN1KMT2ARPS6KA3MAPT
SCHEMBL5363549 0.84 MAPT (0.54) FLT3MEN1KMT2ARPS6KA3MAPT
SCHEMBL5373326 0.82 MAPT (0.70) FLT3MEN1KMT2AMAPTRAF1
SCHEMBL7138923 0.81 NPC1 (0.56) FLT3MEN1KMT2ARPS6KA3MAPT
SCHEMBL7137009 0.80 RAF1 (0.66) FLT3MEN1KMT2ARPS6KA3MAPT
SCHEMBL14674173 0.80 FLT3 (0.76) FLT3MEN1KMT2ARPS6KA3PLK4
SCHEMBL14674172 0.80 FLT3 (0.76) FLT3MEN1KMT2ARPS6KA3PLK4
SCHEMBL29638261 0.80 FLT3 (0.76) FLT3MEN1KMT2ARPS6KA3PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK FLT3 395/4885MEN1 3855/4885KMT2A 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.